Santiago-Andres Y, Aquiles A, Taniguchi-Ponciano K, Salame L, Guinto G, Mercado M
Int J Mol Sci. 2024; 25(7).
PMID: 38612778
PMC: 11011867.
DOI: 10.3390/ijms25073968.
Lenders N, Thompson T, Chui J, Low J, Inder W, Earls P
Pituitary. 2024; 27(3):248-258.
PMID: 38483762
PMC: 11150322.
DOI: 10.1007/s11102-024-01385-0.
Wang W, Ma L, Zhao Y, Liu M, Ye W, Li X
Front Endocrinol (Lausanne). 2023; 14:1216817.
PMID: 37780610
PMC: 10538627.
DOI: 10.3389/fendo.2023.1216817.
Derwich A, Sykutera M, Brominska B, Rubis B, Ruchala M, Sawicka-Gutaj N
Int J Mol Sci. 2023; 24(13).
PMID: 37446128
PMC: 10341524.
DOI: 10.3390/ijms241310952.
Spille D, Vorona E, Catalino M, Reuter G, Beckers A, Holling M
Pituitary. 2022; 26(1):132-143.
PMID: 36508085
PMC: 9908726.
DOI: 10.1007/s11102-022-01291-3.
The outcomes of surgical treatment via transsphenoidal approach for patients with nonfunctioning pituitary adenoma: a single institution's experience.
Choo Y, Seo Y, Kim O
Ann Med. 2022; 54(1):3136-3145.
PMID: 36331312
PMC: 9640163.
DOI: 10.1080/07853890.2022.2140449.
Pituitary adenomas evade apoptosis via noxa deregulation in Cushing's disease.
Asuzu D, Alvarez R, Fletcher P, Mandal D, Johnson K, Wu W
Cell Rep. 2022; 40(8):111223.
PMID: 36001971
PMC: 9527711.
DOI: 10.1016/j.celrep.2022.111223.
Collision Tumor in the Pituitary, Concurrent Pituitary Adenoma, and Craniopharyngioma.
Shareef Z, Kerndt C, Nessel T, Mistry D, Figueroa B
Case Rep Otolaryngol. 2020; 2020:9584090.
PMID: 32963865
PMC: 7495153.
DOI: 10.1155/2020/9584090.
Pituispheres Contain Genetic Variants Characteristic to Pituitary Adenoma Tumor Tissue.
Peculis R, Mandrika I, Petrovska R, Dortane R, Megnis K, Nazarovs J
Front Endocrinol (Lausanne). 2020; 11:313.
PMID: 32528411
PMC: 7256168.
DOI: 10.3389/fendo.2020.00313.
Identification of key genes in invasive clinically non-functioning pituitary adenoma by integrating analysis of DNA methylation and mRNA expression profiles.
Cheng S, Xie W, Miao Y, Guo J, Wang J, Li C
J Transl Med. 2019; 17(1):407.
PMID: 31796052
PMC: 6892283.
DOI: 10.1186/s12967-019-02148-3.
Clinical Presentation and Management of Headache in Pituitary Tumors.
Suri H, Dougherty C
Curr Pain Headache Rep. 2018; 22(8):55.
PMID: 29904889
DOI: 10.1007/s11916-018-0710-8.
Pediatric Pituitary Adenoma: Case Series, Review of the Literature, and a Skull Base Treatment Paradigm.
Perry A, Graffeo C, Marcellino C, Pollock B, Wetjen N, Meyer F
J Neurol Surg B Skull Base. 2018; 79(1):91-114.
PMID: 29404245
PMC: 5796823.
DOI: 10.1055/s-0038-1625984.
Stem/progenitor cells in pituitary organ homeostasis and tumourigenesis.
Haston S, Manshaei S, Martinez-Barbera J
J Endocrinol. 2017; 236(1):R1-R13.
PMID: 28855316
PMC: 5744558.
DOI: 10.1530/JOE-17-0258.
Recent advances in understanding Cushing disease: resistance to glucocorticoid negative feedback and somatic USP8 mutations.
Daniel E, Newell-Price J
F1000Res. 2017; 6:613.
PMID: 28529722
PMC: 5414817.
DOI: 10.12688/f1000research.10968.1.
Human Pituitary Adenoma Proteomics: New Progresses and Perspectives.
Zhan X, Wang X, Cheng T
Front Endocrinol (Lausanne). 2016; 7:54.
PMID: 27303365
PMC: 4885873.
DOI: 10.3389/fendo.2016.00054.
Thyrotropin-secreting pituitary adenomas: epidemiology, diagnosis, and management.
Amlashi F, Tritos N
Endocrine. 2016; 52(3):427-40.
PMID: 26792794
DOI: 10.1007/s12020-016-0863-3.
Structure-Based Screen Identification of a Mammalian Ste20-like Kinase 4 (MST4) Inhibitor with Therapeutic Potential for Pituitary Tumors.
Xiong W, Matheson C, Xu M, Backos D, Mills T, Salian-Mehta S
Mol Cancer Ther. 2016; 15(3):412-20.
PMID: 26721946
PMC: 5820170.
DOI: 10.1158/1535-7163.MCT-15-0703.
Pituitary adenomas: historical perspective, surgical management and future directions.
Theodros D, Patel M, Ruzevick J, Lim M, Bettegowda C
CNS Oncol. 2015; 4(6):411-29.
PMID: 26497533
PMC: 4750488.
DOI: 10.2217/cns.15.21.
Expression profiling of O(6) methylguanine-DNA-methyl transferase in prolactinomas: a correlative study of promoter methylation and pathological features in 136 cases.
Jiang X, Hu B, He D, Mao Z, Wang X, Song B
BMC Cancer. 2015; 15:644.
PMID: 26400193
PMC: 4581044.
DOI: 10.1186/s12885-015-1595-0.
Tumor suppression by MEG3 lncRNA in a human pituitary tumor derived cell line.
Chunharojrith P, Nakayama Y, Jiang X, Kery R, Ma J, De La Hoz Ulloa C
Mol Cell Endocrinol. 2015; 416:27-35.
PMID: 26284494
PMC: 4605874.
DOI: 10.1016/j.mce.2015.08.018.